These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
749 related articles for article (PubMed ID: 23590187)
1. Naltrexone-loaded poly[La-(Glc-Leu)] polymeric microspheres for the treatment of alcohol dependence: in vitro characterization and in vivo biocompatibility assessment. Pagar KP; Vavia PR Pharm Dev Technol; 2014 Jun; 19(4):385-94. PubMed ID: 23590187 [TBL] [Abstract][Full Text] [Related]
2. Poly[LA-(Glc-Leu)] copolymer as a carrier for ocular delivery of ciprofloxacin: formulation, characterization and in vivo biocompatibility study. Pagar KP; Vavia PR Ther Deliv; 2013 May; 4(5):553-65. PubMed ID: 23647274 [TBL] [Abstract][Full Text] [Related]
3. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization. Xu H; Zhong H; Liu M; Xu C; Gao Y Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119 [TBL] [Abstract][Full Text] [Related]
4. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method. Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287 [TBL] [Abstract][Full Text] [Related]
5. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Doan TV; Couet W; Olivier JC Int J Pharm; 2011 Jul; 414(1-2):112-7. PubMed ID: 21596123 [TBL] [Abstract][Full Text] [Related]
6. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
7. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study. Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053 [TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique. Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug. D'Aurizio E; van Nostrum CF; van Steenbergen MJ; Sozio P; Siepmann F; Siepmann J; Hennink WE; Di Stefano A Int J Pharm; 2011 May; 409(1-2):289-96. PubMed ID: 21356295 [TBL] [Abstract][Full Text] [Related]
10. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles. Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348 [TBL] [Abstract][Full Text] [Related]
11. Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. Lewis KJ; Irwin WJ; Akhtar S J Drug Target; 1998; 5(4):291-302. PubMed ID: 9713978 [TBL] [Abstract][Full Text] [Related]
12. Studies on in vitro availability, degradation, and thermal properties of naltrexone-loaded biodegradable microspheres. Akala EO; Wiriyacoonkasem P; Pan G Drug Dev Ind Pharm; 2011 Jun; 37(6):673-84. PubMed ID: 21449706 [TBL] [Abstract][Full Text] [Related]
13. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation. Jiang Y; Wang F; Xu H; Liu H; Meng Q; Liu W Int J Pharm; 2014 Nov; 475(1-2):475-84. PubMed ID: 25219858 [TBL] [Abstract][Full Text] [Related]
14. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release. Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022 [TBL] [Abstract][Full Text] [Related]
15. β-methasone-containing biodegradable poly(lactide-co-glycolide) acid microspheres for intraarticular injection: effect of formulation parameters on characteristics and in vitro release. Song X; Song SK; Zhao P; Wei LM; Jiao HS Pharm Dev Technol; 2013; 18(5):1220-9. PubMed ID: 22295954 [TBL] [Abstract][Full Text] [Related]
16. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method. Kang J; Wu F; Cai Y; Xu M; He M; Yuan W Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681 [TBL] [Abstract][Full Text] [Related]
17. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Doan TV; Olivier JC Int J Pharm; 2009 Dec; 382(1-2):61-6. PubMed ID: 19682562 [TBL] [Abstract][Full Text] [Related]
18. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
19. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Mao S; Xu J; Cai C; Germershaus O; Schaper A; Kissel T Int J Pharm; 2007 Apr; 334(1-2):137-48. PubMed ID: 17196348 [TBL] [Abstract][Full Text] [Related]
20. Zero order controlled release delivery of cholecalciferol from injectable biodegradable microsphere: In-vitro characterization and in-vivo pharmacokinetic studies. Vora L; V G S; Vavia P Eur J Pharm Sci; 2017 Sep; 107():78-86. PubMed ID: 28629804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]